Mobile Health (mHealth) Application for Smoking Cessation Among Adolescents in Indonesia
Development and Evaluation of a Mobile Health (mHealth) Application for Smoking Cessation Among Adolescents in Indonesia: A Mixed Methods Randomized Controlled Trial
1 other identifier
interventional
110
1 country
1
Brief Summary
This mixed-methods study develops and evaluates a mobile health (mHealth) application for smoking cessation among Indonesian adolescents aged 13-15 years. The study uses a sequential exploratory approach with three phases: (1) qualitative research to inform app design; (2) app development using Rapid Application Development (RAD) model; and (3) a single-blind, two-arm randomized controlled trial comparing the mHealth intervention to paper-based materials. The intervention is grounded in the Unified Theory of Acceptance and Use of Technology (UTAUT2) and Transtheoretical Model (TTM). Primary outcome is smoking abstinence at 1-, 3-, and 6-month follow-ups measured through self-report questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 16, 2025
CompletedFirst Posted
Study publicly available on registry
September 30, 2025
CompletedStudy Start
First participant enrolled
March 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 31, 2026
February 4, 2026
February 1, 2026
3 months
September 16, 2025
February 2, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Self-reported smoking abstinence measured through questionnaire (Yes/No response where Yes = abstinent, No = not abstinent)
1, 3, and 6 months post-intervention
Secondary Outcomes (6)
Smoking cessation self-efficacy using SEQ-12 (12-item Smoking Self-Efficacy Questionnaire)
Baseline, 1, 2, 3, and 6 months
Motivation assessed via Richmond Test
Baseline, 1, 2, 3, and 6 months
Social support measured through Multidimensional Scale of Perceived Social Support (MSPSS)
Baseline, 1, 2, 3, and 6 months
Dependence level using Fagerström Test for Nicotine Dependence (FTND)
Baseline, 1, 2, 3, and 6 months
App usage engagement measured through usage logs
Baseline, 1, 2, 3, and 6 months
- +1 more secondary outcomes
Study Arms (2)
mHealth Intervention Group
EXPERIMENTALParticipants receive the mHealth smoking cessation application with: * Educational content about smoking risks and cessation benefits * Motivational messages and progress tracking * Social support features * Interactive elements and quizzes * Monthly monitoring and support
Control Group
ACTIVE COMPARATORParticipants receive paper-based smoking cessation module containing equivalent content: * Motivational content and cessation benefits * Ex-smoker success stories * Trigger identification and coping strategies * Weekly quizzes with prizes (online access) * Monthly check-ins
Interventions
Participants receive the mHealth smoking cessation application with: * Educational content about smoking risks and cessation benefits * Motivational messages and progress tracking * Social support features * Interactive elements and quizzes * Monthly monitoring and support
Participants receive paper-based smoking cessation module containing equivalent content: * Motivational content and cessation benefits * Ex-smoker success stories * Trigger identification and coping strategies * Weekly quizzes with prizes (online access) * Monthly check-ins
Eligibility Criteria
You may qualify if:
- Phase 1 (Qualitative Study):
- Adolescent smokers aged 13-15 years
- Smoking at least one cigarette or vaping once per week
- Key informants: teachers, parents, peers, healthcare workers with relevant experience
- Phase 3 (RCT):
- Adolescents aged 13-15 years
- Smoking at least 1 cigarette in the past week
- Own smartphone with internet access
- Living in Padang City during study period
- Willing to participate until study completion
- Desire to quit smoking
You may not qualify if:
- Phase 3 (RCT):
- Currently using other smoking cessation apps or programs
- Planning to change schools or relocate outside Padang during study period
- Have severe psychiatric or medical conditions requiring intensive treatment
- Unable to use smartphone applications due to literacy or technical limitations
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Multiple junior high schools and community health centers
Padang, West Sumatra, Indonesia
Related Publications (1)
Ilmaskal R, Prabandari YS, Oktaria V. Development and evaluation of a mobile health (mHealth) application for smoking cessation among adolescents in Indonesia: a mixed methods randomised controlled trial study protocol. BMJ Open. 2026 Feb 24;16(2):e112178. doi: 10.1136/bmjopen-2025-112178.
PMID: 41734925DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 16, 2025
First Posted
September 30, 2025
Study Start
March 1, 2026
Primary Completion (Estimated)
May 31, 2026
Study Completion (Estimated)
August 31, 2026
Last Updated
February 4, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- Beginning 3 months and ending 5 years following article publication.
- Access Criteria
- Researchers who provide a methodologically sound proposal. Proposals should be directed to yayisuryo@ugm.ac.id. Data requestors will need to sign a data access agreement.
All individual participant data that underlie the results reported in this article, after deidentification.